Globus Medical sees revenues soar in 2023 after NuVasive merger

Globus Medical on Feb. 20 posted significant revenue growth for the fourth quarter and full year in 2023.

Advertisement

The company reported $616.5 million in fourth quarter sales, an increase of 124.6%, and full year sales of $1.6 billion, a 53.3% increase over the prior year, according to a news release. Globus Medical has also maintained its 2024 guidance range of $2.45 billion to $2.5 billion.

This year will be the first full year Globus Medical will be operating under its merger with NuVasive. In 2024, the company is anticipating the launch of a flagship knee robot.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.